Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
Plaintiff: Merck Sharp & Dohme Corp.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Case Number: 1:2019cv00315
Filed: February 13, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on April 2, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 2, 2019 Opinion or Order SO ORDERED, re #17 STIPULATION TO EXTEND TIME to file Answering Brief to Motion to Dismiss to April 18, 2019 (*Reset Briefing Schedule: re #10 MOTION to Dismiss. Answering Brief due 4/18/2019). Signed by Judge Richard G. Andrews on 4/2/2019. (nms)
April 1, 2019 Filing 17 STIPULATION TO EXTEND TIME Plaintiff to file its Answering Brief to Mylans Motion to Dismiss for Improper Venue and Failure to State a Claim to April 18, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel)
March 28, 2019 Filing 16 REDACTED VERSION of #12 Declaration of Keith Meckstrouth, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 3/28/2019 (nms).
March 28, 2019 Filing 15 REDACTED VERSION of #11 Opening Brief in Support, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 3/28/2019 (nms).
March 28, 2019 Pro Hac Vice Attorneys Deepro R. Mukerjee and Lance A Soderstrom for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
March 28, 2019 Pro Hac Vice Attorney Alissa M. Pacchioli for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
March 26, 2019 Pro Hac Vice Attorney Jitendra Malik for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
March 25, 2019 Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Attorney Deepro R. Mukerjee, Attorney Alissa M. Pacchioli and Attorney Lance A. Soderstrom - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
March 25, 2019 Opinion or Order SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Attorney Deepro R. Mukerjee, Attorney Alissa M. Pacchioli and Attorney Lance A. Soderstrom, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 3/25/2019. (nms)
March 21, 2019 Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Mylan N.V. for Mylan Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
March 21, 2019 Filing 12 [SEALED] DECLARATION of Keith Mockstroth re #11 Opening Brief in Support, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth) Modified on 3/22/2019 (nms).
March 21, 2019 Filing 11 [SEALED] OPENING BRIEF in Support re #10 MOTION to Dismiss for Improper Venue and Failure to State a Claim filed by Mylan Inc., Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 4/4/2019. (Dorsney, Kenneth)
March 21, 2019 Filing 10 MOTION to Dismiss for Improper Venue and Failure to State a Claim - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Dorsney, Kenneth)
March 8, 2019 Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg)
March 8, 2019 Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp)
March 7, 2019 Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg)
March 4, 2019 Filing 9 STIPULATION TO EXTEND TIME for Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. to answer, move or otherwise respond to the Complaint to March 21, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
March 4, 2019 Opinion or Order SO ORDERED, re #9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to March 21, 2019 (*Reset Answer Deadlines: Mylan Inc. answer due 3/21/2019; Mylan Pharmaceuticals Inc. answer due 3/21/2019). Signed by Judge Richard G. Andrews on 3/4/2019. (nms)
February 25, 2019 Filing 8 DECLARATION of Mailing regarding service on Mylan Pharmaceuticals Inc. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms).
February 25, 2019 Filing 7 DECLARATION of Mailing regarding service on Mylan Inc. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms).
February 22, 2019 Opinion or Order SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
February 21, 2019 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb)
February 21, 2019 Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms).
February 14, 2019 Summons Issued with Magistrate Consent Notice attached as to Mylan Inc. on 2/14/2019; Mylan Pharmaceuticals Inc. on 2/14/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)
February 13, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (ceg)
February 13, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708; 8,414,921. (ceg)
February 13, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attached. Date of Expiration of Patent: see attached. (ceg)
February 13, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg)
February 13, 2019 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2569857.) - filed by Merck Sharp & Dohme Corp. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(ceg)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Represented By: Alissa M. Pacchioli
Represented By: Jitendra Malik
Represented By: Kenneth Laurence Dorsney
Represented By: Lance A Soderstrom
Represented By: Deepro R. Mukerjee
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Inc.
Represented By: Alissa M. Pacchioli
Represented By: Jitendra Malik
Represented By: Kenneth Laurence Dorsney
Represented By: Lance A Soderstrom
Represented By: Deepro R. Mukerjee
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme Corp.
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Represented By: Michael P. Kelly
Represented By: Anthony H. Sheh
Represented By: Jingyuan Luo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?